Peroxisome proliferator-activated receptor (PPAR) gamma agonists for diabetes.
Moller
D E
DE
Departments of Metabolic Disorders and Clinical Development Merck Research Laboratories, Rahway, New Jersey 07065, USA.
Greene
D A
DA
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D018160:Receptors, Cytoplasmic and Nuclear / Q000819:agonists*; D014157:Transcription Factors / Q000819:agonists*
D007004:Hypoglycemic Agents; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors